© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
March 16, 2021
A new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
March 10, 2021
The study incorporated diverse populations to determine the association between diets with a high glycemic index and cardiovascular disease risk.
March 04, 2021
Hispanic and Latino adults have a high prevalence of cardiovascular risk factors, but many are receiving inadequate treatment.
March 03, 2021
The American Heart Association published a special issue to discuss current research in cardiovascular disease and outcomes in women.
March 01, 2021
Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.
February 23, 2021
New clinical practice guidelines call for lowering blood pressure levels down to 120 mmHg systolic for those with chronic kidney disease.
February 18, 2021
Once-weekly semaglutide 2.4 mg resulted in sustained reductions in weight for those who are overweight or obese, the investigators reported.
February 16, 2021
Novartis’ sacubitril/valsartan (Entresto) is now indicated for use in the treatment of chronic heart failure.
February 09, 2021
The American Heart Association’s recent scientific statement found that mental health impacts risk factors for heart disease.
Insulin resistance and type 2 diabetes were major contributors to premature coronary heart disease, according to the study results.